News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer
Photo from Peter de Gooyer/LinkedIn
Sep 20, 2024, 13:05

Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer

Top Biomedical Science shared a post on X about a recent paper by Peter de Gooyer et al. published in Nature Medicine.

“Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial”

Authors: Peter de Gooyer, Yara Verschoor, Lauren van den Dungen, Jose van den Berg, Myriam Chalabi et al.

Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer

“Neoadjuvant nivolumab and relatlimab in locally advanced MMR-deficient colon cancer: a phase 2 trial.”

Source: Top Biomedical Science/X

cancer Colon cancer José van den Berg Lauren van den Dungen Myriam Chalabi Nature Medicine OncoDaily Oncology Peter de Gooyer Top Biomedical Science Yara Verschoor
Special Coverage
Blog
Dec 19, 2024, 14:08
Durable Objective Response to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Blog
Dec 19, 2024, 14:04
Patrick Hwu: Celebrating the year and Moffitt Cancer Center's all accomplishments
Blog
Dec 19, 2024, 14:01
The ESMO Asia Congress 2024 was a milestone in advancing oncology research and treatment in Asia-Pacific
Blog
Dec 19, 2024, 13:55
Efficacy of Subsequent Treatments After Disease Progression on CDK4/6 Inhibitors in Hormone Receptor–Positive Breast cancer
Insight
Dec 19, 2024, 13:48
Myeloma Paper of the Day, December 19th, suggested by Robert Orlowski
Blog
Dec 19, 2024, 13:35
OncoInfluencers to Follow on Social Media: Catharine Young
Science
Dec 19, 2024, 13:02
Razelle Kurzrock: Tumor size correlates linearly with outcome after IO in rare cancer
Science
Dec 19, 2024, 12:58
TIGIT and PD-L1 co-blockade promotes clonal expansion of antitumor T cells by Enchancing Co-stimulation
Science
Dec 19, 2024, 12:55
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC
Science
Dec 19, 2024, 12:39
Mayo Clinic Genetic Risk models in Venetoclax-HMA treated AML
Science
Dec 19, 2024, 12:33
Sacituzumab govitecan vs platinum-based chemotherapy for Urothelial Carcinoma - ESMO
Science
Dec 19, 2024, 12:23
ASH: Triplet combination regimens demonstrate high response rates in multiple leukemias